Not yet medically reviewed, information on this site is in preparation and has not been verified by a medical reviewer.
Legality · HHC

HHC in Peru: not individually verified

Not individually verified

We have not confirmed that HHC specifically is scheduled in Peru, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record
Not confirmed. This substance is not carried by Peru's controlling schedule under any name the search reached. Anexo N. 2 of the Reglamento approved by Decreto Supremo 023-2001-SA runs to 244 numbered entries across Listas I A, I B, II A, II B, III A, III B, III C, IV A, IV B, V and VI, and none of them is this substance. The search was run over Anexo N. 2 under hexahidrocannabinol and HHC. Tetrahidrocannabinoles, isomeros y variantes estereoquimicas is carried at Lista II A item 13. Hexahydrocannabinol is saturated in the ring the name tetrahydro describes, so it is not a tetrahydrocannabinol and the class entry does not reach it. The reading was taken from the DIGEMID Catalogo de Sustancias Controladas marked NOVIEMBRE_2024_V1 and cross read against the DIGEMID publication of the same Anexo dated 2021, which is a text only file carrying no images at all. The two publications agree on every list, on the entry at every item number and on the count, and the numbering runs continuously from 1 with no gap in any of the eleven lists, so the absence is taken from a listing read to its end rather than from a truncated one. Matching was anchored at the start of the entry name and every anchored hit was read in full before it was allowed to become a placement. The convention limb of article 2 was run for this row as well and does not reach it: the substance is named in neither the 1971 Convention schedules nor the 1961 Convention schedules, read in the INCB Green List of 2025 and the Yellow List 64th edition of July 2025. The listing read is Anexo N. 2 of the Reglamento approved by Decreto Supremo 023-2001-SA, in the Catalogo de Sustancias Controladas published by the Direccion General de Medicamentos, Insumos y Drogas and marked NOVIEMBRE_2024_V1, which is the version this row was settled against as at 21 September 2026. Article 86 of Decreto Ley 22095 and the closing provisions of that Decreto Ley let the annexed lists be altered by Resolucion Suprema, so reading that version does not rule out a later list. Article 2 of the Reglamento states three limbs: it comprises the substances in the Listas of Decreto Ley 22095, the connected lists of the international conventions incorporated into domestic law, and the substances that may be included under article 86 of that Decreto Ley and article 61 of the Ley General de Salud, and it then says that los listados correspondientes aparecen en el Anexo N. 2. The rule applied across this country set follows those words: where Anexo N. 2 carries an entry its band governs and supersedes the older one, and where Anexo N. 2 is silent the Decreto Ley 22095 annex and the incorporated convention lists can still bring a substance within article 2, so silence in the published catalogue is a gap in it rather than a de-control. Because Anexo N. 2 does not reach this substance and no other Peruvian instrument read in this pass places it, the row is unresolved rather than permitted. Absence from the sanitary schedule is not a statement that the substance may be carried or used, and the position under customs, medicines registration and consumer law was not examined here.

Confirm directly with Peru’s national drug authority or your own embassy before you rely on anything.

What Peru HAS confirmed for related substances

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.